Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP204013.RASmqHb8NJl8Dw00AaLdGepKmaCCFy5CYZzEhKZLKj4g8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP204013.RASmqHb8NJl8Dw00AaLdGepKmaCCFy5CYZzEhKZLKj4g8130_assertion type Assertion NP204013.RASmqHb8NJl8Dw00AaLdGepKmaCCFy5CYZzEhKZLKj4g8130_head.
- NP204013.RASmqHb8NJl8Dw00AaLdGepKmaCCFy5CYZzEhKZLKj4g8130_assertion description "[Although this type of change cannot be detected immunohistochemically in primary tumors without further molecular analysis, the results presented herein indicate that p53 can be detected immunohistochemically in a majority of lung tumors and that there is a tendency for more advanced adenocarcinoma stages to exhibit positive p53 immunostain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP204013.RASmqHb8NJl8Dw00AaLdGepKmaCCFy5CYZzEhKZLKj4g8130_provenance.
- NP204013.RASmqHb8NJl8Dw00AaLdGepKmaCCFy5CYZzEhKZLKj4g8130_assertion evidence source_evidence_literature NP204013.RASmqHb8NJl8Dw00AaLdGepKmaCCFy5CYZzEhKZLKj4g8130_provenance.
- NP204013.RASmqHb8NJl8Dw00AaLdGepKmaCCFy5CYZzEhKZLKj4g8130_assertion SIO_000772 1656762 NP204013.RASmqHb8NJl8Dw00AaLdGepKmaCCFy5CYZzEhKZLKj4g8130_provenance.
- NP204013.RASmqHb8NJl8Dw00AaLdGepKmaCCFy5CYZzEhKZLKj4g8130_assertion wasDerivedFrom befree-20140225 NP204013.RASmqHb8NJl8Dw00AaLdGepKmaCCFy5CYZzEhKZLKj4g8130_provenance.
- NP204013.RASmqHb8NJl8Dw00AaLdGepKmaCCFy5CYZzEhKZLKj4g8130_assertion wasGeneratedBy ECO_0000203 NP204013.RASmqHb8NJl8Dw00AaLdGepKmaCCFy5CYZzEhKZLKj4g8130_provenance.